Jazz Pharmaceuticals plc Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 658.00K shares, a 4600.00% increase from fiscal 2024.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 14.00K shares, a 94.42% decline from fiscal 2023.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 251.00K shares, a 67.70% decline from fiscal 2022.
- Jazz Pharmaceuticals plc share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 777.00K shares, a 25.36% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 658.00K shares 10-K · filed 2026-02-24 | |
| 2024-12-31 | 14.00K shares 10-K · filed 2025-02-26 | |
| 2023-12-31 | 251.00K shares 10-K · filed 2024-02-28 | |
| 2022-12-31 | 777.00K shares 10-K · filed 2023-03-01 | |
| 2021-12-31 | 1.04M shares 10-K · filed 2022-03-01 | |
| 2020-12-31 | 780.00K shares 10-K · filed 2021-02-23 | |
| 2019-12-31 | 515.00K shares 10-K · filed 2020-02-25 | |
| 2018-12-31 | 772.00K shares 10-K · filed 2019-02-26 | |
| 2017-12-31 | 428.00K shares 10-K · filed 2018-02-27 | |
| 2016-12-31 | 398.00K shares 10-K · filed 2017-02-28 | |
| 2015-12-31 | 732.00K shares 10-K · filed 2016-02-23 | |
| 2014-12-31 | 1.19M shares 10-K · filed 2015-02-24 | |
| 2013-12-31 | 904.00K shares 10-K · filed 2014-02-25 | |
| 2012-12-31 | 3.16M shares 10-K · filed 2013-02-26 | |
| 2011-12-31 | 1.42M shares 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |